13F Pro13F Pro

Empery Asset Management, LP

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1469336
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare75.8%$65.5M
  • Consumer Discretionary12.1%$10.4M
  • Communication Services5.1%$4.4M
  • Other2.1%$1.8M
  • Materials1.9%$1.7M
  • Technology1.6%$1.3M
  • Energy1.0%$850,000
  • Financials0.4%$326,912
  • Industrials0.1%$108,461
  • Consumer Staples0.0%$9,250

AUM History

13fpro.ai/research/fund/empery-asset-management-lp-1469336

Conviction and streaks

Diversifying · top 10 = 90.7%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

XFOR$XFORTrimming-23% shares · 2 quarters runningDTIL$DTILTrimming-65% shares · 2 quarters runningTNYA$TNYATrimming-29% shares · 2 quarters running

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/empery-asset-management-lp-1469336

Empery Asset Management, LP 13F holdings — Q2 2026

$86.5M portfolio (+4.2% QoQ) · 32 holdings · Q2 2026 13F · top 10 are 91% of the stock portfolio

All holdings — Empery Asset Management, LP (Q2 2026)

32 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
CYN$CYNCyngn Inc.$1.3M-3%
VENU$VENUVenu Holding Corp$1.2M-49%
GLND$GLNDGreenland Energy Cowarrant$850KNew
URG$URGUR-ENERGY INC$843K—
MSLE$MSLESatellos Bioscience Inc.$833K-53%
JAGU$JAGUJaguar Uranium Corp.$814K—
CLRB$CLRBCellectar Biosciences, Inc.$527KNew
SCYX$SCYXSCYNEXIS INC$515K-93%
RNTX$RNTXRein Therapeutics, Inc.$386KNew
BTCT$BTCTBTC Digital Ltd.$289KNew
— BRIACELL THERAPEUTICS CORP - *W EXP 01/15/203warrant$267K—
MTEK$MTEKMaris Tech Ltd.warrant$58K—
PRZO$PRZOParaZero Technologies Ltd.$55K-60%
DUKR$DUKRDUKE Robotics Corp.warrant$45KNew
NTRB$NTRBNutriBand Inc.warrant$40K—

What changed in Q2 2026

Against the previous quarter's 13F: 11 new, 0 added to, 8 trimmed, 11 sold out. Share-count changes; largest moves by dollar size first.

New positions (11)

  • NGEN$NGENNERVGEN PHARMA CORP.$8.2M

    first bought this quarter

  • CLNN$CLNNClene Inc.$5.6M

    first bought this quarter

  • ANVS$ANVSAnnovis Bio, Inc.$4.5M

    first bought this quarter

  • LTRN$LTRNLantern Pharma Inc.$3.5M

    first bought this quarter

  • AMC$AMCAMC ENTERTAINMENT HOLDINGS, INC.$3.3M

    first bought this quarter

  • ONE AND ONE GREEN TECHNOLOGI - USD CL A ORD SHS$1.5M

    first bought this quarter

+5 more in the Excel export

Added to (0)

No positions added to this quarter.

Trimmed (8)

  • XFOR$XFORX4 Pharmaceuticals, Inc-23%

    now $32.4M · held 3+ qtrs

  • DTIL$DTILPRECISION BIOSCIENCES INC-61%

    now $6.1M · held 3+ qtrs, 2 trims in a row

  • SCYX$SCYXSCYNEXIS INC-93%

    now $515K · held 2 qtrs

  • VENU$VENUVenu Holding Corp-49%

    now $1.2M · held 2 qtrs

  • MSLE$MSLESatellos Bioscience Inc.-53%

    now $833K · held 2 qtrs

  • TNYA$TNYATenaya Therapeutics, Inc.-10%

    now $2.9M · held 3+ qtrs, 2 trims in a row

+2 more in the Excel export

Sold out (11)

  • IMPERIAL PETE INCwas $3.8M
  • U S ENERGY CORP DELwas $1.7M
  • CRML$CRMLCritical Metals Corp.was $1.0M

    held 2+ qtrs

  • PMN$PMNProMIS Neurosciences Inc.was $766K

    held 1 qtr

  • SLE$SLESuper League Enterprise, Inc.was $492K
  • TLPH$TLPHTALPHERA, INC.was $441K

+5 more in the Excel export

Firm AUM (Form ADV): $262.5M as of 2025-12-31 · SEC IAPD

Share

Holdings by quarter

Every 13F Empery Asset Management, LP has filed, 7 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Empery Asset Management?

Q2 2026 13F filed with the SEC on Aug 11, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of Empery Asset Management's top 20 holdings: 22/100 (our AI quality score, weighted by position size; 6 of the 20 are scored)

Top 10 since filing

-21.8%

Value-weighted move of the 10 largest stock positions

Turnover

34%

Last quarter

Top 10 weight

91%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

0%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Empery Asset Management, LP disclosed 32 positions worth $86.5M in its Form 13F-HR for Q2 2026, led by $XFOR (X4 Pharmaceuticals, Inc) at 37.4% of the equity portfolio, followed by $EMPD and $NGEN. During the quarter the fund opened 11 new positions and exited 11 — including a new stake in $NGEN. The portfolio is most concentrated in Healthcare (75.8% of disclosed assets). All figures are sourced directly from Empery Asset Management, LP’s Form 13F-HR filing with the SEC under CIK 1469336.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Empery Asset Management, LP

13F Pro is an AI hedge fund tracker and stock research platform. For Empery Asset Management, LP (SEC CIK: 1469336), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Empery Asset Management, LP's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.